SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Lifesciences India informs about board meeting

03 Feb 2024 Evaluate
SMS Lifesciences India has informed that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024, to consider and approve Unaudited financial results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023; Request of reclassification received from Ramesh Babu, promoter of the Company; Any other item as may be decided by the Board of Directors.

The above information is a part of company’s filings submitted to BSE.

Haleos Labs Share Price

1339.95 39.95 (3.07%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×